Axon Enterprise, Inc. (NASDAQ:AXON – Get Free Report) CEO Patrick W. Smith sold 80,300 shares of the business’s stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $371.78, for a total transaction of $29,853,934.00. Following the completion of the sale, the chief executive officer now directly owns 3,015,366 shares in the company, valued at approximately $1,121,052,771.48. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Axon Enterprise Stock Performance
Shares of NASDAQ:AXON traded up $2.94 on Tuesday, hitting $363.43. The company had a trading volume of 285,960 shares, compared to its average volume of 521,510. Axon Enterprise, Inc. has a 1-year low of $189.12 and a 1-year high of $378.89. The stock has a market cap of $27.46 billion, a price-to-earnings ratio of 105.56, a P/E/G ratio of 9.99 and a beta of 0.95. The stock has a 50 day moving average price of $319.49 and a 200 day moving average price of $305.70. The company has a current ratio of 2.88, a quick ratio of 2.52 and a debt-to-equity ratio of 0.35.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last released its quarterly earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 EPS for the quarter, beating the consensus estimate of $1.02 by $0.18. Axon Enterprise had a net margin of 16.06% and a return on equity of 9.34%. The business had revenue of $504.00 million for the quarter, compared to the consensus estimate of $478.35 million. During the same period in the prior year, the company posted $0.80 earnings per share. Axon Enterprise’s revenue was up 34.5% compared to the same quarter last year. Analysts expect that Axon Enterprise, Inc. will post 1.79 EPS for the current year.
Analyst Upgrades and Downgrades
Check Out Our Latest Report on AXON
Hedge Funds Weigh In On Axon Enterprise
Several institutional investors and hedge funds have recently modified their holdings of the business. ICA Group Wealth Management LLC bought a new stake in Axon Enterprise during the fourth quarter worth about $26,000. Blue Trust Inc. lifted its holdings in shares of Axon Enterprise by 987.5% in the second quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock worth $27,000 after acquiring an additional 79 shares during the last quarter. Trivant Custom Portfolio Group LLC bought a new position in shares of Axon Enterprise in the first quarter worth about $31,000. First PREMIER Bank bought a new position in shares of Axon Enterprise in the first quarter worth about $33,000. Finally, Blue Bell Private Wealth Management LLC bought a new position in shares of Axon Enterprise in the first quarter worth about $41,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.
Axon Enterprise Company Profile
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Featured Articles
- Five stocks we like better than Axon Enterprise
- What is the NASDAQ Stock Exchange?
- Study: How Much Are Retirees Earning from Side Hustles in 2024?
- Quiet Period Expirations Explained
- Brinker International Offers a Pullback Opportunity on EPS Miss
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Globant Is an Emerging AI Play That’s Expanding Its Footprint
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.